References
- WHO, 2012. News releases 2010. Available from: http://www.who.int/mediacentre/news/releases/2010 [last accessed Mar 2012]
- Instituto Nacional do Câncer (INCA). Available from: http//www.inca.gov.br [last accessed 2012]
- Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clin Cancer Res 2003;9:1980–9
- Allred DC, Brown P, Medina D. The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 2004;6:240–5
- Cai Q, Shu XO, Jin F, et al. Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003;12:853–9
- van Duijnhoven FJB, Peeters PHM, Warren RML, et al. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. Cancer Epidemiol Biomarkers Prev 2006;15:462–7
- Ramos EHM, Martinelli S, Silva I, et al. Association between estrogen receptor gene polymorphisms and breast density in postmenopausal women. Climacteric 2009;1:490–501
- González-Mancha R, Galán JJ, Crespo C, et al. Analysis of the ER alpha germline Pvull marker in breast cancer risk. Med Sci Monit 2008;14:136–43
- Javed S, Ali M, Sadia S, et al. Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population. Maturitas 2011;69:377–82
- Boyd NF, Martin LJ, Bronskill M, et al. Breats tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 2010;102:1224–37
- Herrington DM, Howard TD, Hawkins GA, et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346:967–74
- Instituto Brasileiro de Geografia e Estatística (IBGE) [site internet]. Diretoria e pesquisa. Departamento de População e Indicadores Sociais. Available from: http://www.datasus.gov.br/ [last accessed 2012]
- Ray A. Adipokine leptin in obesity-related pathology of breast cancer. J Biosci 2012;37:289–94
- Morimoto LM, White E, Chen Z. Obesity, body size, and risk of post menopausal breast cancer. Cancer Causes Control 2002;13:741–51
- Baer HJ, Colditz A, Rosner B, et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 2005;7:314–25
- Davis AA, Kaklamani VG. Metabolic syndrome and triple-negative breast cancer: a new paradigm. Int J Breast Cancer 2012;2012:809291
- Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. J Natl Cancer Inst 1997;89:488–96
- Trentham-Dietz A, Newcomb PA, Ega KM, et al. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 2000;11:533–42
- Xu H, Xizo W, Luo D, et al. Association analysis of genetic polymorphisms and potential interaction of the oesteocalcin (BGP) and ER-A genes with body mass index (BMI) in premenopausal Chinese women. Acta Pharmacol Sin 2010;31:455–60
- Deng H-W, Li J, Dowd R, et al. Association of estrogen receptor-α genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 2000;85:2748–51
- Wedrén S, Lovmar L, Humphreys K, et al. Oestrogen receptor α gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res 2004;6:437–49
- Esfahlan RJ, Zarghami N, Esfahlan AJ, et al. The possible impact of obesity on androgen, progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients. Breast Cancer Basic Clin Res 2011;5:227–37